☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Sanofi
Sanofi Collaborated with Teva to Co-Develop and Co-Commercialize TEV ‘574 for Inflammatory Bowel Disease
October 4, 2023
Sanofi Entered into an Agreement with Janssen to Develop and Commercialize Vaccine Candidate for Extraintestinal Pathogenic E. Col...
October 3, 2023
Sanofi Receives the MHLW’s Marketing Authorization for Altuviiio to Treat Hemophilia A
September 25, 2023
PharmaShots Weekly Snapshots (June 26 – 30, 2023)
July 1, 2023
Sanofi and SK Bioscience Report Result of GBP410 in P-II Trial to Treat Pneumococcal Diseases in Infants
June 30, 2023
Sanofi Reports P-IIb Study (STREAM-AD) Results of Amlitelimab for the Treatment of Atopic Dermatitis
June 28, 2023
Load more...
Back to Home